Apolipopretein A-I and B Distribution among the Employees and their Partners in Korea

한국인 직장성인과 그 배우자의 Aplipoprotein A-I & B 분포

  • Kim, Won-Sool (Department of Occupational Medicine, College of Medicine, Sungkyunkwan University) ;
  • Kim, Dong-Il (Department of Occupational Medicine, College of Medicine, Sungkyunkwan University) ;
  • Suh, Byung-Sung (Department of Occupational Medicine, College of Medicine, Sungkyunkwan University)
  • 김원술 (성균관의과대학 산업의학교실) ;
  • 김동일 (성균관의과대학 산업의학교실) ;
  • 서병성 (성균관의과대학 산업의학교실)
  • Published : 2007.01.31

Abstract

Objectives : This study was performed to investigate the distribution of apolipoproteins A-I and B among Korean employees and their partners. Methods : The study population consisted of 7,633 men and women (4,578 men and 3,054 women) residing in Seoul and Kyung-gee Do, with an average age of $43.5{\pm}8.3$ years. Blood samples were collected following at least 12 hours of fasting. Apolipoproteins A-I and B were measured using a Behring Nephelometer analyzer. The body mass index (BMI) for each participant was calculated as weight (kg) divided by height squared $(m^2)$. Information on health-related behaviors such as exercise, alcohol intake, and smoking habits was collected through self-administrated questionnaires. Results : The mean concentrations of Apo A-I were $132.6{\pm}22.3mg/dL$ and $142.9{\pm}24.8mg/dL$ in the men and women, respectively. The concentration of Apo A-I increased significantly across all age categories of men. The mean concentrations of Apo B were $101.7{\pm}23.2mg/dL$ and $87.8{\pm}23.5mg/dL$ in the men and women, respectively, and Apo B increased significantly across all age categories for both the men and women. Exercise and BMI were major determinants for Apo A-I and B levels. The 10th percentile of Apo A-I concentration was 109 mg/dL in the men and 113 mg/dL in the women, and the 90th percentile of Apo B concentration was 131 mg/dL in the men and 118 mg/dL women. Conclusions : For the prevention of coronary artery disease, we recommend that for individuals in the 10th percentile of concentration for Apo A-I and the 90th percentile of concentration for Apo B, active preventive interventions such as weight loss and exercise should be taken. This study, within its limitations, may be useful for evaluating apolipoprotein A-I and B concentrations in Korean adults.

Keywords

References

  1. Fodor JG, Frohlich JJ. Recommendations for the management and treatment of dyslipidemia. Report of the working group on hypercholesterolemia and other dyslipidemias. CMAJ 2000; 162(10): 1441-1447
  2. British Cardiac Society, British Hyperlipidemia Association, British Hypertension Society, British Diabetic Association: Joint British recommendations on prevention of coronary heart disease in clinical pratice:summary. BMJ 2000; 320(7236): 705-708 https://doi.org/10.1136/bmj.320.7236.705
  3. Lamarche B, Moorjani S, Lupien PJ. Apolipoprotein AI and B concentrations and the risk of ischemic heart disease during a 5 year follow up of men in the Quebec cardiovascular study. Circulation 1996; 94(3): 273-278 https://doi.org/10.1161/01.CIR.94.3.273
  4. Wallius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E, High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infaction (AMORIS study); A prospective study. Lancet 2001; 358(9298); 2026-2033 https://doi.org/10.1016/S0140-6736(01)07098-2
  5. Talmud PJ, Hawe E, Miller GJ, Humphries SE. Non fasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men. Arterioscler Thromb Vasc Biol 2002; 22(11): 1918-1923 https://doi.org/10.1161/01.ATV.0000035521.22199.C7
  6. Rahmani M, Raiszadeh F, Allaheverdian S, Kiaii S, Navab M, Azizi F. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxanase enzyme activity in Iranian subjects. Atherosclerosis 2002; 162(2): 381-389 https://doi.org/10.1016/S0021-9150(01)00715-8
  7. Laker MF, Evans K. Anlysis of apolipoprotein. Ann Clin. Biochem 1996; 33(Pt1): 5-22
  8. Bhatnagar D, Durrington P. Measurement and Clinical Significance of Apolipoprotein A-I and B, in Rifai N, Warnick GR, Dominiczak M (eds): Handbook of Lipoprotein Testing. Washington, DC, AACC, 1997. pp 177-198
  9. Colvin P, Parks J. Metabolism of high density lipoprotein subfractions. Curr Opin Lipidol 1999; 10(4): 309-314 https://doi.org/10.1097/00041433-199908000-00004
  10. Rosseneu M, Fruchart JC, Bard JM. Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects. The EARS study. Circulation 1994; 89(5): 1967- 1973 https://doi.org/10.1161/01.CIR.89.5.1967
  11. Marcovina SM, Albers JJ, Dati F. International federation of clinical chemistry standardization project for measurement of apolipoproteins A-I and B. Clin Chem 1991; 37(10 Pt1): 1676- 1682
  12. Leino A, Impivaara O, Kaitaari M, Jarvisalo J. Serum concentrations of apolipoprotein A-I, apolipoprotein B and lipoprotein (a) in a finnish sample. Clin Chem 1995; 41(11): 1633-1636
  13. Contosis J, McNamara J, Lammi-Keefe C. Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay : Resukts from the Framingham offspring study. Clin Chem 1996; 42(4): 515-523
  14. Bachorik P, Lovejoy K, Carroll M. Apolipoprotein B and AI distribution in the United States, 1988-1991 : Results of the national health and nutrition examination survey III (NHANES III). Clin Chem 1997; 43(12): 2364-2378
  15. Jungner I, Marcovina S, Walldius G. Apolipoprotein B and A-I values 1n 147,576 Swedish males and female, standardized according to the World Health Organizationinternational federation of clinical chemistry first international reference materials. Clin Chem 1998; 44(8 Pt1): 1641-1649
  16. Victoria Valles, Carlos A, Aguilar-Salinas, Francisco J, Gomez-Perez, Rosalba Rojas, Aurora Franco, Gustavo Olaiz, Juan A, Rull, Jaime Sepulveda. Apolipoprotein B and A-I distribution in Mexican urban adults : Results of a nationwide survey. Metabolism 2002; 51(5): 560-568 https://doi.org/10.1053/meta.2002.31977
  17. Graziani MS, Zanolla L, Righetti G. Plasma apolipoprotein A-I and B in survivors of myocardial infarction and in a control group. Clin Chem 1998; 44(1): 134-140
  18. Durrington PN, Bolton CH, Hartog M. Serum and lipoprotein apolipoprotein B levels in normal subjects and patients with hyperlipoproteinemia. Clin Chim Acta 1978; 82(1-2): 151-160 https://doi.org/10.1016/0009-8981(78)90038-4
  19. Sniderman AD, Wolfson C, Teng B. Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and athersclerosis. Ann Intern Med 1982; 97(6) : 833-839 https://doi.org/10.7326/0003-4819-97-6-833
  20. Sniderman A, Cianflone K. Measurement of apoproteins : Time to improve the diagnosis and treatment of atherrogenic dyslipoproteinemias. Clin Chem 1996; 42(4): 489-491
  21. Karpe F, Bell M, Bjorkegren J. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl palmitate ester labelling and simulataneous measurements of apolipoprotein B-48 and B-100. Arterioscler Thromb 1995; 15(2): 199-207 https://doi.org/10.1161/01.ATV.15.2.199
  22. Assmann G, Schulte H. Results and Conclusions of the Prospective Cardiovascular Munster (PROCAM) Study, in Assmann G (ed): Lipid Metabolism Disorders and Coronary Heart Disease. Munich, Germany, MMV Medizin Verlag, 1993. pp 21-67
  23. Ballantyne C, Grundy SM, Oberman A. Hyperlipidemia : Diagnostic and therapeutic perspectives. J Clin Endocrinol Metab 2000; 85(6): 2089-2112 https://doi.org/10.1210/jc.85.6.2089
  24. Evans K, Laker MF. Intra-individual factors affecting lipid, lipoprotein and apolipoprotein measurement : A review. Ann Clin Biochem 1995; 32(Pt 3): 261-280 https://doi.org/10.1177/000456329503200303
  25. Bhopal R, Unwin N, White M, Yallop J, Walwer L, Alberti, Harland J, Patel S, Asmad N, Turner C, Watson B, Kaur D, Kulkarni A, Laker M, Tavridou A. : Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations : Cross sectional study. BMJ 1999; 319(7204): 215-220 https://doi.org/10.1136/bmj.319.7204.215
  26. Dixon LB, Sudquist J, Kinkleby M. Differences in energy, nutrition and food intakes in a US sample of Mexican American women and men : Finding from the third national health and nutrition examination survey, 1988-1994. Am I Epidemiol 2000; 152(6): 548-557